Tola for drug “Remdesitrivier”: Banning its use in Kosovo

The World Health Organisation's Development Group panel said on Friday that the Remdesivirir drug is not recommended for patients with COVIID-19, despite the fact that there is no evidence that it improves survival rates. While Health Minister Armend Zemaj had promised that the Remdesivir anti-op CO VID, will arrive [...]
While Health Minister Armend Zemaj had promised that the Remdesivir anti-op CO VID, will arrive in Kosovo very soon, infected Ilir Tolaj says that except there are no positive effects, this drug has serious side effects and must be prevented from using it in Kosovo.
The previous “Studies that were not very optimistic about the effect of Remdesivitri in treating the people with COVID-19 were confirmed by the O study. BSH, a study published in the prestigious magazine for BMJ medical studies. According to this study, it turns out that Remdesivir does not even have a positive effect on the performance of COVID-19, while there are serious side effects on the body of people in whom the drug is administered.
It turns out, as well as many times in the history of medicine, that pharmaceutical companies have a huge impact on regulatory agencies that are tasked with protecting the patient, such as the FDA, to allow the use of a drug that has no positive effect at all and has potentially negative effects”, Tolaj said.
Tolaj even adds that institutions in Kosovo should stop using this drug and cancel buying its quantities.
For this, Kosovo health authorities must stop its use in Kosovo and also cancel the purchase of significant amounts of this inefficient drug, which they have warned the media. If they fail to act and if they continue to purchase, then this is a bad sign of their integrity and will arouse serious doubts about their honesty”, Tolaj's response to the signal is said to be further.












